The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Lukshin V.A.

Burdenko Neurosurgical Center

Shulgina A.A.

Burdenko Neurosurgical Center

Usachev D.Yu.

Burdenko Neurosurgical Center

Korshunov A.E.

Burdenko Neurosurgical Center

Belousova O.B.

Burdenko Neurosurgical Center

Lubnin A.Yu.

Burdenko Neurosurgical Center

Ischemic complications following surgical treatment of moyamoya disease: risk factors and prevention

Authors:

Lukshin V.A., Shulgina A.A., Usachev D.Yu., Korshunov A.E., Belousova O.B., Lubnin A.Yu.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2021;85(6): 26‑35

Read: 3924 times


To cite this article:

Lukshin VA, Shulgina AA, Usachev DYu, Korshunov AE, Belousova OB, Lubnin AYu. Ischemic complications following surgical treatment of moyamoya disease: risk factors and prevention. Burdenko's Journal of Neurosurgery. 2021;85(6):26‑35. (In Russ., In Engl.)
https://doi.org/10.17116/neiro20218506126

Recommended articles:
Socio-economic damage caused by elevated low-density lipo­protein cholesterol levels. Medi­cal Technologies. Asse­ssment and Choice. 2025;(2):88-98
A clinical case of treating a patient with severe ischemic stroke and cancer. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):114-117
Early anti­thrombotic protection of the brain in patients with ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):5-10
Resu­lts of the implementation of repe­rfusion technologies in ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):32-39

References:

  1. Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, Marks MP, Steinberg GK. Clinical outcome after 450 revascularization procedures for moyamoya disease. Journal of Neurosurgery. 2009;111(5):927-935.  https://doi.org/10.3171/2009.4.JNS081649
  2. Iwama T, Hashimoto N, Tsukahara T, Murai B. Peri-operative complications in adult moyamoya disease. Acta Neurochirurgica. 1995;132(1-3):26-31.  https://doi.org/10.1007/BF01404844
  3. Sakamoto T, Kawaguchi M, Kurehara K, Kitaguchi K, Furuya H, Karasawa J. Risk factors for neurologic deterioration after revascularization surgery in patients with moyamoya disease. Anesthesia and Analgesia. 1997;85(5):1060-1065. https://doi.org/10.1097/00000539-199711000-00018
  4. Starke RM, Komotar RJ, Connolly ES. Optimal surgical treatment for moyamoya disease in adults: direct versus indirect bypass. Neurosurgical Focus. 2009;26(4):E8.  https://doi.org/10.3171/2009.01.FOCUS08309
  5. Jung YJ, Ahn JS, Kwon DH, Kwun BD. Ischemic complications occurring in the contralateral hemisphere after surgical treatment of adults with moyamoya disease. Journal of Korean Neurosurgical Society. 2011;50(6):492-496.  https://doi.org/10.3340/jkns.2011.50.6.492
  6. Shulgina AA, Lukshin VA, Usachev DYu, Korshunov AE, Belousova OB, Pronin IN. Combined brain revascularization in the treatment of moyamoya disease. Voprosy nejrohirurgii im. N.N. Burdenko. 2021;85(2):47-59. (In Russ.). https://doi.org/10.17116/neiro20218502147
  7. Houkin K, Nakayama N, Kuroda S, Nonaka T, Shonai T, Yoshimoto T. Novel Magnetic Resonance Angiography Stage Grading for Moyamoya Disease. Cerebrovascular Diseases. 2005;20(5):347-354.  https://doi.org/10.1159/000087935
  8. Suzuki J, Takaku A. Cerebrovascular «moyamoya» disease. Disease showing abnormal net-like vessels in base of brain. Archives of Neurology. 1969;20(3):288-299.  https://doi.org/10.1001/archneur.1969.00480090076012
  9. Togao O, Mihara F, Yoshiura T, Tanaka A, Noguchi T, Kuwabara Y, Kaneko K, Matsushima T, Honda H. Cerebral hemodynamics in Moyamoya disease: correlation between perfusion-weighted MR imaging and cerebral angiography. AJNR. American Journal of Neuroradiology. 2006;27(2):391-397. 
  10. Baltsavias G, Khan N, Valavanis A. The collateral circulation in pediatric moyamoya disease. Child’s Nervous System: ChNS. 2015;31(3):389-398.  https://doi.org/10.1007/s00381-014-2582-5
  11. Shulgina AA, Lukshin VA, Shultz EI, Batalov AI, Pronin IN, Usachev DYu. Methods for assessing cerebrovascular insufficiency in patients with moyamoya angiopathy by MR-ASL perfusion. Medicinskaya vizualizaciya. 2021;25(2):102-115. (In Russ.). https://doi.org/10.24835/1607-0763-883
  12. Grubb RL, Powers WJ, Derdeyn CP, Adams HP, Clarke WR. The Carotid Occlusion Surgery Study. Neurosurgical Focus. 2003;14(3):1-7.  https://doi.org/10.3171/foc.2003.14.3.10
  13. Choi JW, Chong S, Phi JH, Lee JY, Kim H-S, Chae JH, Lee J, Kim SK. Postoperative symptomatic cerebral infarction in pediatric moyamoya disease: risk factors and clinical outcome. World Neurosurgery. 2020;136:158-164.  https://doi.org/10.1016/j.wneu.2019.12.072
  14. Kazumata K, Ito M, Tokairin K, Ito Y, Houkin K, Nakayama N, Kuroda S, Ishikawa T, Kamiyama H. The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review. Journal of Neurosurgery. 2014;121(2):432-440.  https://doi.org/10.3171/2014.1.JNS13946
  15. Uchino H, Nakayama N, Kazumata K, Kuroda S, Houkin K. Edaravone reduces hyperperfusion-related neurological deficits in adult moyamoya disease: historical control study. Stroke. 2016;47(7):1930-1932. https://doi.org/10.1161/STROKEAHA.116.013304
  16. Funaki T, Takahashi JC, Takagi Y, Kikuchi T, Yoshida K, Mitsuhara T, Kataoka H, Okada T, Fushimi Y, Miyamoto S. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications. Journal of Neurosurgery. 2015;122(2):400-407.  https://doi.org/10.3171/2014.10.JNS14231
  17. Wei W, Chen X, Yu J, Li XQ. Risk factors for postoperative stroke in adults patients with moyamoya disease: a systematic review with meta-analysis. BMC Neurology. 2019;19(1):1-8.  https://doi.org/10.1186/s12883-019-1327-1
  18. Huang APH, Liu HM, Lai DM, Yang CC, Tsai YH, Wang KC, Yang SH, Kuo MF, Tu YK. Clinical significance of posterior circulation changes after revascularization in patients with moyamoya disease. Cerebrovascular Diseases. 2009;28(3):247-257.  https://doi.org/10.1159/000228254
  19. Czabanka M, Boschi A, Acker G, Pena-Tapia P, Schubert GA, Schmiedek P, Vajkoczy P. Grading of moyamoya disease allows stratification for postoperative ischemia in bilateral revascularization surgery. Acta Neurochirurgica. 2016;158(10):1895-1900. https://doi.org/10.1007/s00701-016-2941-y
  20. Kim SH, Choi JU, Yang KH, Kim TG, Kim DS. Risk factors for postoperative ischemic complications in patients with moyamoya disease. Journal of Neurosurgery. 2005;103(5):433-438.  https://doi.org/10.3171/ped.2005.103.5.0433
  21. Iwama T, Hashimoto N, Yonekawa Y. The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease. Neurosurgery. 1996;38(6):1120-1125; discussion 1125-11256. https://doi.org/10.1097/00006123-199606000-00011
  22. Yusa T, Yamashiro K. Local cortical cerebral blood flow and response to carbon dioxide during anesthesia in patients with moyamoya disease. Journal of Anesthesiah. 1999;13(3):131-135.  https://doi.org/10.1007/s005400050043
  23. Nomura S, Kashiwagi S, Uetsuka S, Uchida T, Kubota H, Ito H. Perioperative management protocols for children with moyamoya disease. Child’s Nervous System: ChNS. 2001;17(4-5):270-274.  https://doi.org/10.1007/s003810000407
  24. Sun H, Wilson C, Ozpinar A, Safavi-Abbasi S, Zhao Y, Nakaji P, Wanebo JE, Spetzler RF. Perioperative Complications and Long-Term Outcomes After Bypasses in Adults with Moyamoya Disease: A Systematic Review and Meta-Analysis. World Neurosurgery. 2016;92:179-188.  https://doi.org/10.1016/j.wneu.2016.04.083

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.